Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1984 Nov;52(2):719–721. doi: 10.1128/jvi.52.2.719-721.1984

Identification of a new neutralization antigenic site on poliovirus coat protein VP2.

E A Emini, B A Jameson, E Wimmer
PMCID: PMC254583  PMID: 6208380

Abstract

Major neutralization antigenic sites have been previously mapped by us on VP1, the largest capsid protein of poliovirus type 1. Here we report the first identification of the primary sequence of a neutralization antigenic site on capsid protein VP2. Inspection of the amino acid sequence of VP2 led to the selection and synthesis of a peptide (n = 12) that, after linking to a carrier protein, induced an antiviral neutralizing antibody response in rabbits. The response was augmented by a single subsequent inoculation of intact virus; thus, the peptide was also capable of priming the production of neutralizing antibodies. These antibodies were directed only against the site specified by the synthetic peptide. Although the VP2-specific neutralization antigenic site appears not to be strongly immunogenic in the intact virion, it can nevertheless contribute to neutralization of poliovirus. This observation may be important for the development of peptide vaccines.

Full text

PDF
719

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beatrice S. T., Katze M. G., Zajac B. A., Crowell R. L. Induction of neutralizing antibodies by the coxsackievirus B3 virion polypeptide, VP2. Virology. 1980 Jul 30;104(2):426–438. doi: 10.1016/0042-6822(80)90345-1. [DOI] [PubMed] [Google Scholar]
  2. Beneke T. W., Habermehl K. O., Diefenthal W., Buchholz M. Iodination of poliovirus capsid proteins. J Gen Virol. 1977 Feb;34(2):387–390. doi: 10.1099/0022-1317-34-2-387. [DOI] [PubMed] [Google Scholar]
  3. Chou P. Y., Fasman G. D. Structural and functional role of leucine residues in proteins. J Mol Biol. 1973 Mar 5;74(3):263–281. doi: 10.1016/0022-2836(73)90372-0. [DOI] [PubMed] [Google Scholar]
  4. Dernick R., Heukeshoven J., Hilbrig M. Induction of neutralizing antibodies by all three structural poliovirus polypeptides. Virology. 1983 Oct 15;130(1):243–246. doi: 10.1016/0042-6822(83)90134-4. [DOI] [PubMed] [Google Scholar]
  5. Dorner A. J., Dorner L. F., Larsen G. R., Wimmer E., Anderson C. W. Identification of the initiation site of poliovirus polyprotein synthesis. J Virol. 1982 Jun;42(3):1017–1028. doi: 10.1128/jvi.42.3.1017-1028.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Emini E. A., Elzinga M., Wimmer E. Carboxy-terminal analysis of poliovirus proteins: termination of poliovirus RNA translation and location of unique poliovirus polyprotein cleavage sites. J Virol. 1982 Apr;42(1):194–199. doi: 10.1128/jvi.42.1.194-199.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Emini E. A., Jameson B. A., Lewis A. J., Larsen G. R., Wimmer E. Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies. J Virol. 1982 Sep;43(3):997–1005. doi: 10.1128/jvi.43.3.997-1005.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Emini E. A., Jameson B. A., Wimmer E. Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature. 1983 Aug 25;304(5928):699–703. doi: 10.1038/304699a0. [DOI] [PubMed] [Google Scholar]
  9. Emini E. A., Kao S. Y., Lewis A. J., Crainic R., Wimmer E. Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies. J Virol. 1983 May;46(2):466–474. doi: 10.1128/jvi.46.2.466-474.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Evans D. M., Minor P. D., Schild G. S., Almond J. W. Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3. Nature. 1983 Aug 4;304(5925):459–462. doi: 10.1038/304459a0. [DOI] [PubMed] [Google Scholar]
  11. Ey P. L., Prowse S. J., Jenkin C. R. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry. 1978 Jul;15(7):429–436. doi: 10.1016/0161-5890(78)90070-6. [DOI] [PubMed] [Google Scholar]
  12. Kitamura N., Adler C., Wimmer E. Structure and expression of the picornavirus genome. Ann N Y Acad Sci. 1980;354:183–201. doi: 10.1111/j.1749-6632.1980.tb27967.x. [DOI] [PubMed] [Google Scholar]
  13. Kitamura N., Semler B. L., Rothberg P. G., Larsen G. R., Adler C. J., Dorner A. J., Emini E. A., Hanecak R., Lee J. J., van der Werf S. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature. 1981 Jun 18;291(5816):547–553. doi: 10.1038/291547a0. [DOI] [PubMed] [Google Scholar]
  14. Larsen G. R., Anderson C. W., Dorner A. J., Semler B. L., Wimmer E. Cleavage sites within the poliovirus capsid protein precursors. J Virol. 1982 Jan;41(1):340–344. doi: 10.1128/jvi.41.1.340-344.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lonberg-Holm K., Butterworth B. E. Investigation of the structure of polio- and human rhinovirions through the use of selective chemical reactivity. Virology. 1976 May;71(1):207–216. doi: 10.1016/0042-6822(76)90106-9. [DOI] [PubMed] [Google Scholar]
  16. Minor P. D., Schild G. C., Bootman J., Evans D. M., Ferguson M., Reeve P., Spitz M., Stanway G., Cann A. J., Hauptmann R. Location and primary structure of a major antigenic site for poliovirus neutralization. Nature. 1983 Feb 24;301(5902):674–679. doi: 10.1038/301674a0. [DOI] [PubMed] [Google Scholar]
  17. Niman H. L., Houghten R. A., Walker L. E., Reisfeld R. A., Wilson I. A., Hogle J. M., Lerner R. A. Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. Proc Natl Acad Sci U S A. 1983 Aug;80(16):4949–4953. doi: 10.1073/pnas.80.16.4949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nomoto A., Omata T., Toyoda H., Kuge S., Horie H., Kataoka Y., Genba Y., Nakano Y., Imura N. Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc Natl Acad Sci U S A. 1982 Oct;79(19):5793–5797. doi: 10.1073/pnas.79.19.5793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Racaniello V. R., Baltimore D. Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc Natl Acad Sci U S A. 1981 Aug;78(8):4887–4891. doi: 10.1073/pnas.78.8.4887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Rothberg P. G., Harris T. J., Nomoto A., Wimmer E. O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus. Proc Natl Acad Sci U S A. 1978 Oct;75(10):4868–4872. doi: 10.1073/pnas.75.10.4868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rowlands D. J., Clarke B. E., Carroll A. R., Brown F., Nicholson B. H., Bittle J. L., Houghten R. A., Lerner R. A. Chemical basis of antigenic variation in foot-and-mouth disease virus. Nature. 1983 Dec 15;306(5944):694–697. doi: 10.1038/306694a0. [DOI] [PubMed] [Google Scholar]
  22. Semler B. L., Anderson C. W., Hanecak R., Dorner L. F., Wimmer E. A membrane-associated precursor to poliovirus VPg identified by immunoprecipitation with antibodies directed against a synthetic heptapeptide. Cell. 1982 Feb;28(2):405–412. doi: 10.1016/0092-8674(82)90358-0. [DOI] [PubMed] [Google Scholar]
  23. Semler B. L., Hanecak R., Anderson C. W., Wimmer E. Cleavage sites in the polypeptide precursors of poliovirus protein P2-X. Virology. 1981 Oct 30;114(2):589–594. doi: 10.1016/0042-6822(81)90242-7. [DOI] [PubMed] [Google Scholar]
  24. Semler B. L., Hanecak R., Dorner L. F., Anderson C. W., Wimmer E. Poliovirus RNA synthesis in vitro: structural elements and antibody inhibition. Virology. 1983 Apr 30;126(2):624–635. doi: 10.1016/s0042-6822(83)80018-x. [DOI] [PubMed] [Google Scholar]
  25. Shinnick T. M., Sutcliffe J. G., Green N., Lerner R. A. Synthetic peptide immunogens as vaccines. Annu Rev Microbiol. 1983;37:425–446. doi: 10.1146/annurev.mi.37.100183.002233. [DOI] [PubMed] [Google Scholar]
  26. Stanway G., Cann A. J., Hauptmann R., Hughes P., Clarke L. D., Mountford R. C., Minor P. D., Schild G. C., Almond J. W. The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1. Nucleic Acids Res. 1983 Aug 25;11(16):5629–5643. doi: 10.1093/nar/11.16.5629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Toyoda H., Kohara M., Kataoka Y., Suganuma T., Omata T., Imura N., Nomoto A. Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants. J Mol Biol. 1984 Apr 25;174(4):561–585. doi: 10.1016/0022-2836(84)90084-6. [DOI] [PubMed] [Google Scholar]
  28. Wetz K., Habermehl K. O. Specific cross-linking of capsid proteins to virus RNA by ultraviolet irradiation of poliovirus. J Gen Virol. 1982 Apr;59(Pt 2):397–401. doi: 10.1099/0022-1317-59-2-397. [DOI] [PubMed] [Google Scholar]
  29. Wetz K., Habermehl K. O. Topographical studies on poliovirus capsid proteins by chemical modification and cross-linking with bifunctional reagents. J Gen Virol. 1979 Aug;44(2):525–534. doi: 10.1099/0022-1317-44-2-525. [DOI] [PubMed] [Google Scholar]
  30. Wimmer E., Jameson B. A., Emini E. A. Poliovirus antigenic sites and vaccines. Nature. 1984 Mar 1;308(5954):19–19. doi: 10.1038/308019a0. [DOI] [PubMed] [Google Scholar]
  31. van der Marel P., Hazendonk T. G., Henneke M. A., van Wezel A. L. Induction of neutralizing antibodies by poliovirus capsid polypeptides VP1, VP2 and VP3. Vaccine. 1983 Dec;1(1):17–22. doi: 10.1016/0264-410x(83)90007-5. [DOI] [PubMed] [Google Scholar]
  32. van der Werf S., Wychowski C., Bruneau P., Blondel B., Crainic R., Horodniceanu F., Girard M. Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1. Proc Natl Acad Sci U S A. 1983 Aug;80(16):5080–5084. doi: 10.1073/pnas.80.16.5080. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES